The Hospital for the Ruptured and Crippled: William Bradley Coley, third Surgeon-in-Chief 1925-1933
1Weill Medical College of Cornell University, New York, NY, USA. levinedb@hss.edu
Insights
William Bradley Coley, a pioneer in cancer treatment, became Surgeon-in-Chief at the Hospital for the Ruptured and Crippled. His groundbreaking work in cancer immunology later faced challenges but was continued by his daughter.
Area of Science:
- Medical History
- Oncology
- Immunology
Background:
- William Bradley Coley, a prominent surgeon, was appointed Surgeon-in-Chief of the Hospital for the Ruptured and Crippled (R & C) in 1925.
- Coley was renowned for his pioneering work in using toxins to treat malignant tumors, particularly sarcomas.
- He had a long and distinguished career, graduating from Yale College and Harvard Medical College, and holding positions at various New York hospitals.
Purpose of the Study:
- To detail the career of William Bradley Coley, focusing on his leadership at the Hospital for the Ruptured and Crippled.
- To highlight Coley's significant contributions to surgical treatments, including hernias and cancer immunotherapy.
- To provide historical context on the acceptance and eventual decline of Coley's toxin-based cancer treatments.
Main Methods:
- Historical review of Coley's career and appointments.
- Examination of his contributions to surgical techniques and cancer treatment.
- Documentation of the legacy and subsequent efforts to revive his immunotherapy research.
Main Results:
- Coley's appointment marked the first time a general surgeon led the nation's oldest orthopedic hospital.
- His innovative approach to cancer treatment using toxins, while initially influential, eventually fell out of favor.
- His daughter, Helen Coley Nauts, continued his work in cancer immunotherapy after his death.
Conclusions:
- William Bradley Coley was a pivotal figure in the history of surgery and oncology.
- His legacy includes advancements in hernia repair and early, albeit controversial, cancer immunotherapy.
- The persistence of his daughter underscores the enduring interest in immunotherapy for cancer treatment.
Abstract:
In January 1925, the Board of Managers of the New York Society for the Relief of the Ruptured and Crippled appointed William Bradley Coley, M.D., age 63, Surgeon-in-Chief of the Hospital for the Ruptured and Crippled (R & C) to succeed Virgil P. Gibney who submitted his resignation the month before. It would be the first time a general surgeon held that position at the oldest orthopedic hospital in the nation, now known as Hospital for Special Surgery (HSS). Coley had been on staff for 36 years and was world famous for introducing use of toxins to treat malignant tumors, particularly sarcomas. A graduate of Yale College and Harvard Medical College, Coley interned at New York Hospital and was appointed, soon after, to the staff of the New York Cancer Hospital (now Memorial Sloan Kettering Cancer Center) located at that time at 106th Street on the West Side of New York. With his mentor Dr. William Bull, Coley perfected the surgical treatment of hernias at R & C. He was instrumental in raising funds for his alma maters, Yale, Harvard and Memorial Hospital. His crusade in immunology as a method of treatment for malignant tumors later fell out of acceptance in the medical establishment. After his death in 1936, an attempt to revive interest in use of immunotherapy for inoperable malignancies was carried out by his daughter, Helen Coley Nauts, who pursued this objective until her death at age 93 in 2000. Coley's health deteriorated in his later years, and in 1933, he resigned as chief of Bone Tumors at Memorial Hospital and Surgeon-in-Chief at R & C, being succeeded at Ruptured and Crippled as Surgeon-in-Chief by Dr. Eugene H. Pool. William Bradley Coley died of intestinal infarction in 1936 and was buried in Sharon, Connecticut.
Related Concept Videos
Hospitals-II
Nurses that work in hospitals have...
Aneurysm III: Interprofessional Care
Hospitals-I
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Tertiary Healthcare System
Pneumothorax-II
Clinical Manifestations:

